Tuva B. Dahl
Oslo University Hospital(NO)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Atherosclerosis and Cardiovascular Diseases, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis(2007)465 cited
- → LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues(2006)234 cited
- → Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies(2011)182 cited
- → Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology(2012)179 cited
- → Atherosclerotic Plaque Stability—What Determines the Fate of a Plaque?(2008)145 cited
- → Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19(2021)121 cited
- → Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease(2010)101 cited
- → Interleukin 23 Levels Are Increased in Carotid Atherosclerosis(2015)100 cited
- → Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations(2022)82 cited
- → Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis(2014)80 cited